• 1. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 2. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 5. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids and derivatives Piperidinecarboxylic acids

Introduction to Tert-butyl 4-(methoxymethyl)piperidine-1-carboxylate (CAS No. 509147-78-8)

Tert-butyl 4-(methoxymethyl)piperidine-1-carboxylate, with the chemical formula C₁₂H₂₁N₁O₃, is a significant compound in the field of pharmaceutical chemistry and drug development. This compound, identified by its CAS number 509147-78-8, has garnered attention due to its unique structural properties and potential applications in medicinal chemistry. The presence of a tert-butyl group and a piperidine ring makes it a versatile intermediate for synthesizing various bioactive molecules.

The Tert-butyl 4-(methoxymethyl)piperidine-1-carboxylate moiety is particularly interesting because it combines the stability provided by the tert-butyl group with the functional flexibility of the piperidine ring. This combination makes it an attractive candidate for further derivatization, enabling the creation of novel compounds with tailored pharmacological properties. In recent years, there has been a growing interest in piperidine derivatives due to their role in developing drugs that target neurological and cardiovascular diseases.

One of the most compelling aspects of this compound is its utility in the synthesis of piperidine-based scaffolds. Piperidine derivatives are known for their ability to enhance drug solubility and bioavailability, making them valuable in pharmaceutical formulations. The methoxymethyl group attached to the piperidine ring introduces additional reactivity, allowing for further functionalization through esterification or other chemical transformations. This reactivity is particularly useful in designing prodrugs or drug analogs that can be activated in vivo to release the active pharmaceutical ingredient (API).

Recent research has highlighted the potential of Tert-butyl 4-(methoxymethyl)piperidine-1-carboxylate in developing treatments for central nervous system (CNS) disorders. Studies have demonstrated that piperidine derivatives can modulate neurotransmitter receptors, such as serotonin and dopamine receptors, which are implicated in conditions like depression, anxiety, and Parkinson's disease. The tert-butyl group enhances metabolic stability, while the methoxymethyl moiety provides a site for further chemical modifications, making this compound a promising candidate for CNS drug development.

In addition to its applications in CNS disorders, Tert-butyl 4-(methoxymethyl)piperidine-1-carboxylate has shown promise in the treatment of cardiovascular diseases. Piperidine-based compounds have been investigated for their ability to inhibit enzymes involved in lipid metabolism and blood pressure regulation. The structural features of this compound allow it to interact with biological targets in a way that promotes cardiovascular health. For instance, derivatives of piperidine have been found to reduce cholesterol levels and improve endothelial function, which are critical factors in preventing heart disease.

The synthesis of Tert-butyl 4-(methoxymethyl)piperidine-1-carboxylate involves multi-step organic reactions that require precise control over reaction conditions. The tert-butyl group is typically introduced via tert-butylation reactions, while the methoxymethyl group can be incorporated through alkylation or etherification processes. Advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions, have been employed to achieve high yields and purity levels. These synthetic methods are essential for ensuring that the final product meets pharmaceutical standards and is suitable for further development.

Quality control and analytical techniques play a crucial role in characterizing Tert-butyl 4-(methoxymethyl)piperidine-1-carboxylate. High-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry (MS) are commonly used to confirm the identity and purity of the compound. These analytical methods provide detailed information about the molecular structure and help ensure that the compound meets regulatory requirements before it can be used in drug development.

The pharmacokinetic properties of Tert-butyl 4-(methoxymethyl)piperidine-1-carboxylate are another area of interest. Studies have shown that piperidine derivatives exhibit favorable pharmacokinetic profiles, including good oral bioavailability and moderate metabolic clearance rates. These properties make them suitable for once-daily dosing regimens, which improve patient compliance and convenience. Additionally, the metabolic stability provided by the tert-butyl group allows for longer half-lives, reducing the frequency of administration required.

In conclusion, Tert-butyl 4-(methoxymethyl)piperidine-1-carboxylate (CAS No. 509147-78-8) is a versatile compound with significant potential in pharmaceutical research and development. Its unique structural features make it an excellent intermediate for synthesizing bioactive molecules targeting various diseases, particularly those affecting the central nervous system and cardiovascular system. Advances in synthetic chemistry and analytical techniques continue to enhance our ability to develop novel drugs based on this compound, paving the way for innovative treatments.

• 123855-51-6(tert-butyl 4-(hydroxymethyl)piperidine-1-carboxylate)
• 921199-39-5(tert-butyl 4-(oxiran-2-yl)piperidine-1-carboxylate)
• 374794-96-4(tert-butyl 2-oxa-8-azaspiro[4.5]decane-8-carboxylate)
• 919360-69-3(tert-butyl 4-(3-hydroxy-2-methylpropyl)piperidine-1-carboxylate)
• 240401-27-8(tert-Butyl 2-oxa-7-azaspiro[3.5]nonane-7-carboxylate)
• 236406-38-5(tert-Butyl 4-(2-hydroxyethyl)-4-(hydroxymethyl)piperidine-1-carboxylate)
• 236406-21-6(1-Boc-4-(hydroxymethyl)-4-methyl-piperidine)
• 509147-79-9(tert-Butyl 4-(2-methoxyethyl)piperidine-1-carboxylate)
• 374795-47-8(tert-Butyl 2-oxa-9-azaspiro[5.5]undecane-9-carboxylate)
• 312638-87-2(4-Cyclohexyl-4-(hydroxymethyl)-N-(tert-butoxycarbonyl)piperidine)